Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.21.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Schedule of Information About Reported Segment Profit or Loss and Assets
B. Information about reported segment profit or loss and assets

 

   

Breast

Cancer Test

   

 

Alzheimer

    COVID-19 testing    

 

Total

 
                         
Year ended December 31, 2020                                
Revenues     -       -       5,207       5,207  
Operating loss     (4,943 )     (8,327 )     (991 )     (14,081 )
Unallocated amounts:                                
Financing expenses, net                             (14,(312  
Share in losses of affiliated companies accounted for under equity method, net                             (1,200 )
Net loss     (4,943 )     (8,327 )     (991 )     (29,773 )
Total assets     1,554       -       4,455       6,009  
Other significant items:                                
Total expenditures for assets of reportable segments     24       -       2,006       2,030  
Total depreciation for reportable segments     (28 )     -       (68 )     (96 )

Summary of Revenues by Geographic Region
C. Revenues by geographic region are as follows:

 

   

Year ended

December 31

 
    2020     2019  
             
Israel   $ -     $ -  
United States     5,207       -  
    $ 5,207     $ -  

Summary of Property and Equipment, Net, by Geographic Area
D. Property and equipment, net, by geographic areas:

 

   

As of

December 31,

 
    2020     2019  
Israel   $ 61     $ 65  
United States     1,938       -  
    $ 1,999     $ 65